G57321FI

Summary
GlyTouCan ID
G57321FI
IUPAC Condensed
GalNAc(a1-
Motifs
Tn antigen
GlyConnect structure
GlyGen
ChEBI
PubChem Compound
PubChem Substance
The Human Metabolome Database
3D Structures
GlycoNAVI
G57321FI
GLYCAM
DGalpNAca1-OH
GlycoShape
Organisms
Taxonomic Hierarchy
GlycoGene Database (GGDB)
Displaying all 4 entries
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Product Reducing terminal(Product) Reference
C1GALT1 (not applicable)
G57321FI
Ser/Thr
G00031MO
Ser/Thr
ST6GALNAC1 CMP-Neu5Ac
G57321FI
Ser/Thr
G36123IU
Ser/Thr
ST6GALNAC1 CMP-Neu5Ac
G57321FI
O-glycan Synthesis
G36123IU
O-glycan Synthesis
B3GNT6 UDP-GlcNAc
G57321FI
[alpha]-pNP
G00035MO
[alpha]-pNP
Displaying entries 1 - 5 of 9 in total
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Product Reducing terminal(Product) Reference
C1GALT1 (not applicable)
G57321FI
Ser/Thr
G00031MO
Ser/Thr
ST6GALNAC1 CMP-Neu5Ac
G57321FI
Ser/Thr
G36123IU
Ser/Thr
ST6GALNAC4 CMP-Neu5Ac
G57321FI
benzyl
G36123IU
benzyl
ST6GALNAC1 CMP-Neu5Ac
G57321FI
O-glycan Synthesis
G36123IU
O-glycan Synthesis
ST6GALNAC1 CMP-Neu5Ac
G57321FI
[Ala-Thr(*)-Ala]2-7
G36123IU
[Ala-Thr(*)-Ala]2-7
Displaying entries 26 - 30 of 35 in total
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Reference
GCNT1 UDP-GlcNAc
G57321FI
A4GNT UDP-GlcNAc
G57321FI
[alpha]pNP
B3GNT7 UDP-GlcNAc
G57321FI
[alpha]-Bz
B3GNT8 UDP-GlcNAc
G57321FI
[alpha]-Bz
B3GNT7 UDP-GlcNAc
G57321FI
[alpha]-O-pNP
GlycoEpitope
Epitope ID
EP0021
Pathway
Displaying entries 1 - 10 of 57 in total
Pathway Name Organism
E.coli O101 Escherichia coli
E.coli O103 Escherichia coli
E.coli O107 Escherichia coli
E.coli O112ab Escherichia coli
E.coli O112ac Escherichia coli
E.coli O116 Escherichia coli
E.coli O117 Escherichia coli
E.coli O125ab Escherichia coli
E.coli O127 Escherichia coli
E.coli O128ab-H27 Escherichia coli
Sequence Descriptors
GlycoCT
RES
1b:a-dgal-HEX-1:5
2s:n-acetyl
LIN
1:1d(2+1)2n
WURCS
WURCS=2.0/1,1,0/[a2112h-1a_1-5_2*NCC/3=O]/1/
Literature
Displaying entries 171 - 180 of 2052 in total
PubMed ID Title First Author Publication Date Source
32502344 Dual-Probe Approach for Mass Spectrometric Quantification of MUC1-Specific Terminal Gal/GalNAc In Situ Sun B 2020 Jun 05
  • PubChem
32119947 H-type lectins – Structural characteristics and their applications in diagnostics, analytics and drug delivery Pietrzyk-Brzezinska AJ 2020 Jun 01
  • PubChem
32726826 The Evolution of Hemophilia Care: Clinical and Laboratory Advances, Opportunities, and Challenges Trinchero A 2020 Jul 29
  • PubChem
32578997 Cysteine Aminoethylation Enables the Site-Specific Glycosylation Analysis of Recombinant Human Erythropoietin using Trypsin Lippold S 2020 Jul 21
  • GlyGen
  • PubChem
32681153 Large-scale site-specific mapping of the O-GalNAc glycoproteome Yang W 2020 Jul 17
  • PubChem
32535887 Bariatric surgery decreases oxidative stress and protein glycosylation in patients with morbid obesity Carmona-Maurici J 2020 Jul 13
  • PubChem
32005975 C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer Lee PC 2020 Jan 31
  • PubChem
31932717 Molecular basis for fibroblast growth factor 23 O-glycosylation by GalNAc-T3 de las Rivas M 2020 Jan 13
  • PubChem
32161592 Activation of the C-Type Lectin MGL by Terminal GalNAc Ligands Reduces the Glycolytic Activity of Human Dendritic Cells Zaal A 2020 Feb 25
  • PubChem
32034693 Givosiran: First Approval Scott LJ 2020 Feb 08
  • PubChem
PubAnnotation
Displaying entries 6 - 9 of 9 in total
Title Authors Source Publication Date PubMed ID
Immunological response from an entirely carbohydrate antigen: design of synthetic vaccines based on Tn-PS A1 conjugates.
  • De Silva RA
  • Wang Q
  • Chidley T
  • Appulage DK
  • Andreana PR
J Am Chem Soc 2009 Jul 22 19552408
Two different glycosyltransferase defects that result in GalNAc alpha-O-peptide (Tn) expression.
  • King MJ
  • Chan A
  • Roe R
  • Warren BF
  • Dell A
  • Morris HR
  • Bartolo DC
  • Durdey P
  • Corfield AP
Glycobiology 1994 Jun 7949653
Localization of O-glycan initiation, sphingomyelin synthesis, and glucosylceramide synthesis in Vero cells with respect to the endoplasmic reticulum-Golgi intermediate compartment.
  • Schweizer A
  • Clausen H
  • van Meer G
  • Hauri HP
J Biol Chem 1994 Feb 11 8307959
Carbohydrate receptor-mediated gene transfer to human T leukaemic cells.
  • Thurnher M
  • Wagner E
  • Clausen H
  • Mechtler K
  • Rusconi S
  • Dinter A
  • Birnstiel ML
  • Berger EG
  • Cotten M
Glycobiology 1994 Aug 7827404

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.2.1

Last updated: April 7, 2025